HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Offers Complex And Fast Tracks: Not All Advertising Claim Reviews Are Alike

Industry Self-Regulation Group Responds To Advertisers’ Suggestions

Executive Summary

NAD will assign three attorneys at the beginning of each Complex Track review instead of one, director Laura Brett said in a recent interview. The industry self-regulation group also recently launched its Fast-Track program for more simple ad claim challenges that rarely have been made.

You may also be interested in...



NAD Says Fast-Track SWIFT Reviews Doubled Over Past Year

Greater awareness of Fast-Track SWIFT and improved understanding of cases appropriate for the process have nearly doubled the number of SWIFT cases evaluated by the National Advertising Division over the past 12 months, NAD attorney Daniel Range said at the NAD 2022 conference in Washington.

NAD Lacks Visibility Into Hair-Care Brand’s ‘192,000 5-Star Reviews’ Claim, Advises Discontinuation

The BBB National Programs division was not afforded adequate information about how Prose garners and aggregates reviews from customers, leading the NAD to side with challenger Function, Inc. The NAD suggests that Prose’s review-and-revise process for improving customers’ personalized hair-care formulas should be disclosed as part of any future claim about star ratings. 

Mead Johnson's Quick Response To Nestlé Nutrition Formula Claim Challenge Isn't Swift Enough

Mead Johnson pulls challenged claims before National Advertising Division began a review in its SWIFT process, but not before Nestlé Nutrition, which markets Gerber infant formula, submitted its challenge.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS150465

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel